Programme
The IDF Virtual Congress 2023 programme is organised across four streams:
- Cardiovascular disease and hypertension
- Eye and kidney
- Foot and neuropathy
- Diabetes in crisis
Programme at a glance
All times are Central European Time (CET). View this interactive time zone map to see the corresponding times in your area.
Monday, December 4
Tuesday, December 4 -
Thursday, December 7
10:00 - 11:30
11:30 - 11:45
11:45 - 13:15
13:15 - 13:30
13:30 - 14:30
14:30 - 14:45
14:45 - 16:15
Scientific session
IDF Diabetes Atlas
Movement break
Satellite symposia
Movement break
Scientific session
Movement break
Scientific session
IDF Diabetes Atlas
10:00 - 11:00
11:00 - 11:10
11:10 - 12:10
12:10 - 12:20
12:20 - 12:50
12:50 - 13:00
13:00 - 14:00
14:00 - 14:15
14:15 - 15:15
15:15 - 15:30
15:30 - 16:15
16:15 - 16:45
Scientific sessions
Movement break
Scientific sessions
Movement break
Meet-the-expert
Movement break
Satellite symposia
Movement break
Scientific sessions
Movement break
Poster presentation
Meet-the-expert
Monday, December 4
10:30-11:30: IDF Diabetes Atlas 10th Edition Launch - Part 1
13:00-13:15: Movement break
13:15-14:45: Celebrating 100 years of insulin
14:45-15:00: Movement break
15:00-16:15: Satellite symposium
16:15-16:30: Movement break
16:15-17:15: IDF Diabetes Atlas 10th Edition Launch - Part 2
Tuesday, 7 December
10:15-11:45: Satellite symposium
12:00-13:30: Session
13:30-13:45: Movement break
13:45-14:45: Satellite symposium
14:45-15:00: Movement break
15:00-16:30: Session
16:30-16:45: Movement break
16:45-17:15: Poster presentation
Wednesday 8 - Saturday 11 December
12:00-13:30: Session
13:30-13:45: Movement break
13:45-14:45: Satellite symposium
14:45-15:00: Movement break
15:00-16:30: Session
16:30-16:45: Movement break
16:45-17:15: Poster presentation
Types of sessions
Scientific Sessions
Symposium
Our 30+ 90 minutes symposia sessions will be an integral part of our congress and will be delivered by internationally acclaimed scientists in the field of diabetes care. They will display the latest findings in diabetes research and current issues in therapy and education. All symposia will include a live Q&A at the end of the session.
Debate
Hear from two opposing teams that will defend and refute current topics on diabetes. Don’t hesitate to share your opinion at the end of the debate.
Teaching lecture
Recognised experts will give educational lectures on specific topics. This format will combine a lecture with a question-and-answer session.
Seminar
Specific topics will be discussed accompanied by practical demonstrations, problem-solving or hands-on training sessions.
Interactive Sessions
The IDF Virtual Congress 2021 places great emphasis on networking and interactivity and encourages participants to update their profile after logging in. This will help to connect with professionals who share similar interests. Our digital congress platform provides a great networking tool. By clicking on the Networking icon, you can connect with other participants and exchange messages through the chat tool or invite them for a chat through a video call.
Meet-the-Expert Sessions
Don’t miss the opportunity to address your questions directly to a leading expert. Our Meet-the-Expert networking sessions will be limited to a small number of participants to allow for maximum interaction with the expert on a specific topic.
Panel discussions
Participate in an interactive session encouraging discussion between groups of diverse panellists. A moderator will ask the panellists questions to start a conversation followed by an audience Q&A.
Delegate discussion groups
Spark a memorable conversation in our chat rooms and create your own group topic to trigger a fruitful discussion or join a pre-defined topic on the following subjects:
- Do we understand and are we responding to the psychological drivers and consequences of diabetes complications?
- Current and future challenges of Covid-19 and how the virus affects people with diabetes
- Cardiovascular risks in diabetes across the globe: share your experience
- What are the best strategies to improve adherence to foot self-care in people with and without active ulcers?
- Treatment of diabetic kidney disease
Poster Sessions
E-poster gallery
The IDF Virtual Congress will provide you with the opportunity to hear about the latest research in diabetes care from a global audience of diabetes health professionals. You will have full access to 400+ posters in our e-poster gallery and will be able to view them during the event and up to 12 months after the Congress. You will be able to browse posters by keyword and have the opportunity to contact the abstract authors through our messaging system.
Oral poster presentation
Our best abstracts are selected for an oral poster presentation in our “Best Poster” sessions in the scientific programme.
Some sessions will also include an interactive polling feature to help expand your knowledge and exchange best practices.
All sessions will be broadcast live during the congress and made available available on-demand for 30 days after the congress. During the live sessions, you will be able to join a live Q&A with delegates and speakers from across the globe.
Programme highlights
 |
Global overview of the diabetic footProf Abdul Basit will provide an overview of the the diabetic foot in the IDF Middle-East and North Africa Region, highlighting the importance of the multidisciplinary team in reducing amputation rates. |
 |
Heart failure and diabetes: diagnosis and phenotypesDr. Søren Lund Kristensen will discuss the risk and clinical presentation of heart failure in people with diabetes and how this differs from heart failure in people without diabetes, in terms of management and prognosis. |
The variability in the trajectory of diabetic kidney diseaseProf. Juliana Chan will discuss the importance of regular assessment, quality care and new technologies in dramatically changing the outcome of diabetic kidney disease. |
Autonomic neuropathyProf. Karen Jones will discuss the clinical diagnosis and management of gastrointestinal autonomic neuropathy. |
 |
COVID-19 and Diabetes: The Indian Experience – Prevention and clinical managementDr. V. Mohan will provide a broad overview of the relationship between COVID-19 and diabetes in India, the health outcomes resulting from the virus and the importance of prevention and management in reducing the severity of COVID-19 in people with diabetes. |
 |
Why do some individuals with diabetes develop kidney disease?Prof Mark Cooper will discuss the multi-omics approaches that are increasingly being examined to identify and monitor the progression of diabetic kidney disease in people living with diabetes. |
 |
Management of somatic neuropathyProf Paul Thornalley will describe the evidence of abnormally low levels of vitamins in clinical diabetic neuropathy and the effect of vitamin supplements. |
 |
Targeting high triglycerides in diabetes: when and how?Prof David Preiss will discuss the promise of future therapies which substantially lower triglycerides, including those working through the lipoprotein lipase pathway. |
 |
Psychosocial aspects of diabetes complicationsDr Amelia Lake will introduce brief, opportunistic, health behaviour change conversations to promote uptake of screening in primary care and improve diabetes-related outcomes. |
 |
My diabetes story and the things that made a difference for mePakistan cricket legend Wasim Akram will share his journey with type 1 diabetes. |
Therapeutic challenges for people with diabetesProf. Anoop Misra will discuss the use of non-insulin blood glucose lowering drugs in people with type 2 diabetes and COVID-19. |
Should aspirin be reserved for secondary prevention in type 2 diabetes?Prof. Bianca Rocca and Prof. Jane Armitage will debate whether aspirin should be reserved for secondary prevention in type 2 diabetes. |
Current clinical management updates for COVID-19 and diabetesProf. Kamlesh Khunti will report on the epidemiology of type 2 diabetes & Covid-19 and describe the methods of improving care for people with diabetes during the pandemic. |
 |
Practical approach to antibiotic choice for infected ulcersDr. Edgar Peters will discuss the diagnosis and management of foot ulcers and provide an overview of the practical approach to antibiotic choice for infected ulcers. |
 |
Diagnosis and management of foot ulcersDr. Vijay Viswanathan will discuss the simple methods that can be used by physicians to make a proper diagnosis of diabetes-related foot ulcers and their risk factors. |
 |
Smart technology and new methodology in neuropathy and foot problemsProf Solomon Tesfaye will present the “one-stop shop” screening for neuropathy and high risk foot. |
 |
Mobile apps for detection and diagnosis of foot problemsProf Neil Reeves will discuss how artificial intelligence can be used to automatically detect diabetic foot ulcers and related pathologies. |
 |
Hypertension – UpdatesProf Kazem Rahimi will present new insights into blood pressure lowering and cardiovascular risk reduction. |
 |
Diabetes complications: the experiences of people with diabetes and the health professionals who manage themStela Prgomelja will share her story of developing and living with a kidney complication of diabetes. |
 |
Diagnosis and surgical management of sight-threatening diabetic eye diseasesProf Noemi Lois will review the complications of diabetic retinopathy and discuss why, despite advances in diabetic retinopathy screening, people still lose sight as a result of the condition. |
 |
Risk prediction and coronary artery disease in diabetesProf Nikolaus Marx will discuss if there is a true distinction between primary and secondary prevention in diabetes. |
 |
Diabetic eye and other complications of diabetesProf. Rufino Silva will discuss biomarkers to detect progression of diabetic eye disease. |
Continuing Medical Education
The IDF Virtual Congress 2021 has been accredited with 18 hours of CME credits from the European Accreditation Council for Continuing Medical Education (EACCME). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
CME certificates will be available for participants after the Congress.
